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Objective: To understand the mechanisms of postpartum uterine involution, we investigated the uterine
myometrial changes during pregnancy and the postpartum period.
Materials and methods: Nine groups of uterine myometrial samples from mice (n ¼ 4) were collected on
gestational Day 0 (nonpregnant), Day 1, Day 2, Day 7, Day 14, and Day 21 and on postpartum Day 1, Day 2,
and Day 7. Human samples of uterinemyometrium on term (n¼ 1) and postpartumDay 1 (n¼ 2)were also
collected. Ki-67 immunostaining was used to determine myometrial proliferation. For cell hypertrophy
analysis, organelle proteins, b-actin, prohibin, calnexin, and golgin-97 were analyzed byWestern blotting.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and evaluation of
activated caspase-3 expression by Western blot analysis assay were used to detect apoptosis. Autophagy
was assayed via the evaluation of LC3 expression by Western blotting, immunohistochemistry, and
autophagosomes by electron microscopy.
Results: Uterine myocytes proliferated during the early stage of gestation with a peak at Day 2, whereas
myocyte hypertrophy with increased cellular organelle production occurred gradually in later stages of
pregnancy. Postpartum autophagy developed abruptly in uterine myocytes without obvious apoptosis.
Conclusion: Autophagy of myocytes may play an important role in uterine involution. These results have
implications for our understanding of myometrial functional adaptations during pregnancy and the
physiological role of autophagy in the uterine remodeling events in the postpartum period.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
The human uterus undergoes profound physiological tissue
remodeling during pregnancy and involution during the post-
partum period. Dramatic increases in uterine size to accommodate
the growing fetus occur and the uterus very rapidly returns to the
initial (before pregnancy) level after delivery. It has been estimated
that the nonpregnant parous uterus weighs approximately 70 g,
and at term, the uterus weighs approximately 1100 g, representing
an almost 20-fold increase in mass [1,2].
The myometrium, the distinct muscular layer of the uterine wall
that is involved in contraction during labor, is the main components and Gynecology, Chi Mei
bstetrics & Gynecology. Publishedin the enlargement of the uterus during pregnancy. It consists
predominantly of smooth muscle cells but also contains ﬁbroblasts,
blood and lymphatic vessels, immune cells, and connective tissue.
The connective tissue, or stroma, provides a supportive matrix for
the bundles of smooth muscle, and a framework that expands as
the uterus distends during gestation. The size and number of
myometrial smooth muscle cells are determined by the stage of
pregnancy [3].
The cellular andmolecular responses of myometrial cells to both
biochemical and biophysical changes during this period are not
fully known. At the cellular level, an individual myometrial cell
might enlarge almost 100-fold to approximately 500 mm in length
at term. This is a reversible process, and the cell is maintained in a
differentiated status and undergoes hypertrophy instead of hy-
perplasia in response to various stimuli during pregnancy. As
pregnancy progresses, the cell body steadily enlarges but involutesby Elsevier Taiwan LLC. All rights reserved.
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delivery in humans.
Following parturition, the uterus recovers its prepregnancy size
with some weight gain. Although the postpartum involution of the
uterus has been studied previously [4e7], the mechanisms
responsible for the reduction in size and number of muscle cells are
still not fully understood. Myocyte apoptosis and/or autophagy in
the postpartum period has been suggested in uterine involution.
Takamoto et al [4] and Shkurupiy et al [5] suggested that uterine
smooth muscle undergoes apoptosis in uterine involution, whereas
Gray et al [6] suggested that it did not. Using electron microscopy
examination, Henell et al [7] suggested that autophagy is a likely
mechanism responsible for the size reduction observed in uterine
involution.
Autophagy is a lysosomal degradation pathway for cytoplasmic
material, which is activated during stress conditions, such as amino
acid starvation [8,9]. In general, mammalian cells use autophagy
during short periods of starvation to degrade nonessential cellular
components to liberate nutrients for vital biosynthetic reactions.
The process is characterized by the formation of double membrane
vacuoles containing cytoplasmic constituents, the autophago-
somes. These autophagosomes are fused with lysosomes to form
the autolysosomes, which subsequently degrade the sequestered
material. It is a survival mechanism for cells under nutrient star-
vation. Excessive autophagic activity may lead to cellular death
[10e12]. However, the role of autophagy in uterine involution in
the postpartum period has not been fully explored.
We hypothesize that autophagy is an important mechanism in
uterine involution. Therefore, in this study, we investigated the
uterine myometrial changes during pregnancy including myome-
trium hyperplasia, as demonstrated by nuclear Ki-67 expression
and hypertrophy, as measured by uterine weight gain and
increased cellular organelle production. Because of a potential role
in uterine involution, we also examined myometrial apoptosis via a
terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling (TUNEL) assay and caspase-3 activation. Finally, we stud-
ied the autophagy activity of myometrium derived from mice as
well as from human samples. We found that myometrial hyper-
plasia occurs mainly in early gestation, whereas cellular hypertro-
phy with increase cellular organelle production occurs in later
stages of pregnancy. After parturition, autophagy occurs abruptly in
uterine involution without an increase of myocyte apoptosis. The
results have implications for our understanding of myometrial
functional adaptations during pregnancy, and the physiological role
of autophagy in the uterine remodeling events in the postpartum
period.
Materials and Methods
Cell culture and reagents
The cervical cancer HeLa cell line was purchased from American
Type Culture Collection (ATCC; Rockville, MD, USA). The cells were
maintained in Dulbecco Modiﬁed Eagle Medium (DMEM) supple-
mented with 10% fetal bovine serum, 100 units/mL penicillin and
100mg/mL streptomycin (Life Technologies, Inc., Carlsbad, CA, USA)
in a humidiﬁed atmosphere of 5% CO2. Cisplatin was obtained from
Sigma Chemical Company (St Louis, MO, USA).
Antibodies against calnexin (1:2000), golgin-97, and actin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Anticleaved caspase-3 (Asp175) and antiprohibin antibodies were
obtained from Cell Signaling Technology (Beverly, MA, USA) and
Lab Vision Products Thermo Fisher (Fremont, CA, USA).
Antimicrotubule-associated protein 1 light chain 3 antibody (LC3,
1:1000, Code No. PM036) was obtained from MBL InternationalCorporation (Nagoya, Japan). Rat monoclonal anti-mouse Ki-67
antibody (clone TEC-3) was obtained from Dako (Carpinteria, CA,
USA). Mouse monoclonal antisera raised against smooth muscle
calponin (C2687, clone hCP) and a b-actin antibody were obtained
from Sigma-Aldrich (Oakville, ON, Canada). Calponin was used as a
standard control because calponin expression levels are consistent
throughout pregnancy [13,14].
Animals
Female Imprinting Control Region mice (ICR mice) (8 weeks old)
were mated with male ICR mice. The different stages of the estrous
cycle in the mice were determined by cytologic examination of
vaginal smears. Day 1 of gestationwas designated as the daya vaginal
plug was observed. The average time to delivery under these condi-
tionswas approximately 3weeks. TermwasonDay 21. Themicewere
maintained in a speciﬁc pathogen-free animal care facility. The
experimental protocol adhered to the rules of the Animal Protection
Act of Taiwan and was approved by the Laboratory Animal Care and
Use Committee of National Cheng Kung University, Tainan, Taiwan.
Tissue collection and preparation
The mice were sacriﬁced and the uterine myometrial samples
were collected on gestational Day 0 (nonpregnant), Day 1, Day 2,
Day 7, Day 14, and Day 21 as well as on postpartum Day 1, Day 2,
and Day 7. On each day of gestation, tissue was collected from four
different mice and processed separately (n ¼ 4). Because we
examinedmice segments of the uterine horn and onemouse uterus
has 8e10 segments, we sacriﬁced only four mice in each group. To
determine the myometrial weight of each segment of the uterine
horn (1 uterine segment contains 1mouse fetus, as shown between
the red arrows in Fig. 1A), the segments of uterine horns from
different gestational days and postpartum days were cut. The
endometrium, mouse fetus, and placenta in the fertilized uterus
were carefully removed by scraping the luminal surface of the
uterus using a scalpel blade under a dissecting microscope (Nikon
SMZ-2T, Nikon Corp, Tokyo, Japan). For protein extraction, the
uterine horns were placed into ice-cold phosphate buffered saline
(PBS) and bisected longitudinally. After removing the endome-
trium, fetus, and placenta, the remainingmousemyometrial tissues
were immediately snap frozen in liquid nitrogen and stored
at 80C for subsequent protein analyses. For immunohistochem-
ical studies, the intact uterine horns were cross-sectioned, cut into
segments using a scalpel blade, and placed in formalin for ﬁxation
and embedded in parafﬁn. For the human uterine samples, three
archival formalin-ﬁxed, parafﬁn-embedded uterine specimens
were retrieved from the Department of Pathology, Chi Mei Medical
Center, Liouying, Tainan, Taiwan. The myometrial tissue was ob-
tained either at the term, during a scheduled cesarean section or
from samples obtained during postpartum hysterectomies. The
sampled patients received a hysterectomy 1 day after delivery
because of uncontrolled postpartum uterine atony. A histopatho-
logic examination of the samples indicated a normal myometrium.
Immunohistochemistry
Immunohistochemistry was performed as previously reported
with somemodiﬁcations [15]. Brieﬂy, 4-mm-thick sections were cut
sequentially from the archival specimens, dewaxed with xylene,
and rehydrated through the use of graded alcohol. After blocking
endogenous peroxidase activity, the sections were subjected to
heat-induced antigen retrieval using an autoclave and then incu-
bated with Ki-67 antibodies at 4C overnight. The LC3 immuno-
histochemical detection procedure was based on a protocol that
Fig. 1. Uterine growth and myometrial weight changes during pregnancy. (A) Gross
pictures of mouse uterine horns at various gestational and postpartum days.
Bar ¼ 1 cm. P0 indicates nonpregnancy; P2, P7, P14 and P21 indicate Day 1, Day 7, Day
14, and Day 21 of gestation respectively; PP1 and PP7 indicate postpartum at Day 1 and
Day 7 respectively. (B) Weight changes of a segment of the uterine horn (indicated
between red arrows in Fig. 1A) during pregnancy and postpartum. After carefully
removing the endometrium, mouse fetus as well as placenta under dissecting micro-
scopy, the remaining myometrium tissues were weighed. The myometrium weight
reached a peak at term, Day 21 of pregnancy, a statistically signiﬁcant difference
compared with the other time points (***p < 0.01). Its weight returned to prepreg-
nancy levels on approximately PP7.
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Detection was accomplished using streptavidin-biotinylated
peroxidase-conjugated reagents (LSAB kit; Dako). For negative
controls, normal rabbit serum or isotype mouse antibodies were
used at the same concentration as primary antibodies.
Western blot analysis
Frozen mouse myometrial tissue samples were homogenized
using the MagNA Lyser System (Roche Applied Science, Mannheim,
Germany) in modiﬁed RIPA lysis buffer [50 mM Tris-HCl (pH 7.5),
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodiumdodecyl sulfate, 1 mM sodium pyrophosphate, 1 mM phenyl-
methylsulphonyl ﬂuoride (PMSF), 1 mM Na3VO4, 1 mM NaF, and a
protease inhibitor cocktail (Sigma Chemical Company)]. The sam-
ples were centrifuged at 12,000g at 4C for 15 minutes, and the
supernatants were collected. The protein concentrations were
determined using Bio-Rad (Hercules, CA, USA) DC Protein Assay
reagents. The proteins from the lysates of mice uterine myome-
trium at different gestational days were resolved using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and transferred
to the Hybond-P polyvinylidene diﬂuoride (PVDF) transfer mem-
brane (Amersham Biosciences, Buckinghamshire, UK). The mem-
brane was blocked in blocking buffer (5% nonfat milk powder,
1  TBS, 0.1% Tween-20) for 1 hour followed by overnight incu-
bation with the primary antibody at 4C, and was sequentially
incubated for 1 hour at room temperature with horseradish
peroxidase-conjugated secondary antibody. Antibody binding was
detected by enhanced chemiluminescence with the use of the
Luminol Reagent (Santa Cruz Biotechnology) or Immobilon West-
ern chemiluminescent HRP substrate (Millipore, Billerica, MA, USA)
followed by exposure to X-ray ﬁlms or the BioSpectrum Imaging
System (UVP, Upland, CA, USA).
TUNEL assays
A DeadEnd colorimetric TUNEL assay kit (Promega, Madison,
WI, USA) was used to detect apoptotic cells in situ [17]. Brieﬂy, the
tissue sections were deparafﬁnized and rehydrated by sequentially
immersing the slides through graded ethanol washes, ﬁxed with 4%
paraformaldehyde in PBS, and washed with PBS. TUNEL-positive
cells with dark brown staining were observed and counted under
a light microscope.
Electron microscopy
In addition to the biochemical measurement of autophagy ac-
tivity with the LC3 assays, morphologic studies were performed
using electron microscopy. For autophagosome observation, an
electronmicroscopewas used as previously described [10]. Mice on
postpartum Day 1 (PP1), postpartum Day 2 (PP2), and postpartum
Day 7 (PP7) were anesthetized with pentobarbital (50 mg/kg
intraperitoneal injection) and sacriﬁced. Tissue ﬁxation with
continued perfusion with a modiﬁed pulsatile roller pump (10 mL/
minute; pulsation rate 90/minute) with a ﬁxative (2% para-
formaldehyde and 1.25% glutaraldehyde in 0.1 M phosphate buffer,
pH 7.2) through the left heart ventricles was performed [18]. The
uteri were removed and postﬁxed in the same ﬁxative for 2 hours.
The myometria were blocked into 1 mm3 cubes and ﬁxed in a 1%
aqueous solution of OsO4for 1 hour. The specimens were washed
with double distilled H2O for 30 minutes three times and were
dehydrated in increasingly powerful graded ethanol from 50% to
100% and pure propylene oxide. The samples were embedded in
Epon at room temperature for 12 hours and polymerized in an oven
at 55

C for 1 day. Ultrathin sections of the samples (80 nm) were
then cut from the blocks and then contrasted with lead citrate and
uranyl acetate. The samples were examined with a Hitachi 7650
electron microscope (Hitachi, Tokyo, Japan).
Statistical analysis
The results are expressed as the mean ± standard deviation.
Statistically signiﬁcant differences among the groups were evalu-
ated with the use of an analysis of variance (ANOVA) or a Kruskal-
Wallis test. The Newman-Keuls test was used for post-ANOVA in-
dividual comparison of the means. A value of p < 0.05 was
considered signiﬁcant.
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Uterine enlargement and myometrial weight increase as pregnancy
progresses
Pregnancy was associated with a dramatic increase in uterine
size (Fig. 1A), which was obviously reversed on postpartum Day 1.
We determined the myometrial weight of each speciﬁc segment of
the uterine horn (indicated by the red arrows in Fig.1A) at particular
time points. The weight at P2 was 18.0 ± 0.5 mg (mean ± standard
deviation). Theweight was 36.3 ± 3.9mg at P7, 79.6± 3.8mg at P14,
105.7 ± 5.0mg at P21, 65.9± 5.3mg at PP1, and 13.7 ± 1.6mg at PP7,
respectively (Fig.1B). Theweight of the segment had reached a peak
at term Day 21, with a statistically signiﬁcant difference in weight
compared with the other time points (***p < 0.01). It returned to
pregestational status before PP7.Fig. 2. Cellular hypertrophy and increased organelle protein expression of the myocytes du
different gestational days. C ¼ circular muscle of myometrium. Note the progressive increase
following speciﬁc organelle marker proteins: b-actin for the cytoskeleton, prohibin for mitoc
Note the organelle proteins increase along with pregnancy progression and decrease in theProgressive hypertrophy and increase in organelle proteins of the
uterine myocytes during pregnancy
We determined cellular hypertrophy morphologically with he-
matoxylin and eosin staining of the cross-section of the uterine
horns at various gestational days. As seen in Fig. 2A, there is a pro-
gressive increase in myocyte size as pregnancy progresses and a
decrease in the postpartum period. In addition, myocyte organelle
protein expression also progressively increasedwith pregnancy and
decreased in the postpartum period. As seen in Fig. 2B, the expres-
sion of various organelle proteins, including b-actin (cytoskeleton),
prohibin (mitochondria), calnexin (endoplasmic reticulum), and
golgin-97 (Golgi apparatus) were determined by Western blotting,
and the expression of all these proteins increased as pregnancy
progressedbutdecreased in thepostpartumperiod.As thecontentof
calponin, a smooth muscle-speciﬁc protein associated with the thinring pregnancy. (A) Representative hematoxylin and eosin stain of the uterine horns at
s in the cell size of myocytes. Bar ¼ 100 mm. (B) Representative Western blotting for the
hondria, calnexin for the endoplasmic reticulum, and golgin-97 for the Golgi apparatus.
postpartum period. Calponin was used as standard loading control.
K.-F. Hsu et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 293e302 297ﬁlaments, is not different in the myometrium during of pregnancy
[13,14], it was used as a control in Western blotting experiments.
Uterine myocytes proliferate in the early stage of gestation
To determine if hyperplasia accompanies the hypertrophy of the
myocytes of the uterus during pregnancy, we performed immuno-
stainingwithKi-67, a cell proliferationmarker, in themyometriumat
different gestational time points and postpartum. Nuclear-stained
cells were considered to be positive cells (arrows, Fig. 3A). Ki-67-
positive myometrial cells throughout gestation and in the post-
partum period were quantitatively expressed as percentages of
positive cells in four mice on each speciﬁc day with ﬁve sections for
each animal. At a minimum, ﬁve ﬁelds of each slide were examined
for each gestational day and a total of 2000 cells were counted
as previously reported [19]. The percentages of Ki-67-positive myo-
cytes in themyometriumacross thepregnancyandpostpartumwereFig. 3. Uterine myocytes proliferate during the early stage of gestation in the mice. (A) R
myometrium at speciﬁc days of pregnancy and postpartum. Cells with positive nuclear stain
during gestation and the postpartum period were quantitatively expressed as a percentage o
point, and a total of 2000 cells were counted. The bars represent the mean ± standard devia
indicated by ***p < 0.01.as follows P1: 10.6% ± 1.6% (mean ± standard deviation), P2:
16.4% ± 0.9%, P7: 7.6% ± 1.6%, P14: 6.1% ± 2.4%, P21: 3.3% ± 0.9%, PP1:
3.2% ± 0.8%, PP2: 2.8% ± 0.5, and PP7: 2.5% ± 1.0% (Fig. 3B). A cell
proliferation peak occurred at P2 (p < 0.01 versus other gestational
days) and decreased gradually throughout the pregnancy and the
postpartum period.
Apoptosis of uterine myocytes does not increase at the postpartum
stage
To understand whether apoptosis is involved in uterine invo-
lution, two apoptosis detection methods (TUNEL assay that de-
termines the cleavage of the genomic DNA into small fragments
before cell membrane disintegration and evaluation of activated
caspase-3 expression, the main executioner caspase in apoptosis
[11]) were applied to examine the uterine myometrium on various
days of gestation and in the postpartum period. As shown in Fig. 4A,epresentative immunohistochemical stain of a cell proliferation marker, Ki-67, in the
ing of Ki-67 are indicated by arrows. Bar ¼ 50 mm. (B) Ki-67 -positive myometrial cells
f positive cells. As a minimum, ﬁve sections for each slide were examined at each time
tion. A signiﬁcant difference between gestational Day 2 and the other gestational day is
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all negative for TUNEL staining. Because apoptosis occurs cyclically
in a nonpregnant endometrium, uterine endometrial sections of
nonpregnant mouse uteri in the metestrus phase were also used as
a positive control in TUNEL staining. Moreover, the Western blot
analysis of activated caspase-3 was also used to conﬁrm the results.
Apoptosis of the uterine myocytes did not increase during the
postpartum period (Fig. 4B). HeLa cells treated with 50 mM cisplatin
for 24 hours (HeLa þ cis) were used as a positive control.
Postpartum autophagy occurs in uterine myocytes
To elucidate the role of autophagy in uterine involution, we ﬁrst
examined the LC3 expression levels in the uterine myometrium on
different gestational days by Western blot analysis and electron
microscopy. LC3, a mammalian orthologue of yeast ATG8, is
commonly used as a marker of autophagosome formation [20]. LC3Fig. 4. Apoptosis in the uterine myocytes does not increase in the mice postpartum. (A) R
postpartum day 2 (PP2) and (d) postpartum day 7 (PP7). (a) The metestrus phase of the mou
serial sections of uterine myometrium of the mice at (a) metestrus, (b) PP1, (c) PP2, (d) PP7
middle panel. Note that no apoptotic myocytes were observed at these postpartum. (B) In t
cleavage product) of the uterine myometrium at PP1, PP2, and PP7. HeLa cells treated for 24 h
cisplatin (HeLa) were used as a negative control. In the left side panel, a TUNEL assay of HeLa
Note that no activation of caspase-3 was observed on PP1, PP2, PP7.is cleaved to form LC3-I, which displays cytosolic distribution. Dur-
ing induction of autophagy, LC3-I is conjugated to the lipid phos-
phatidylethanolamine to form LC3-II, which is tightly bound to the
membrane of the autophagosomes [21]. As seen in Fig. 5A, therewas
an abrupt increase in the expression of LC3-II in the myometrium at
PP1, which gradually decreased at PP7. To further verify postpartum
myometrial autophagy, we examined the myometrium with trans-
mission electron microscopy and found multiple autophagic vacu-
oles (autophagosomes) that containedmitochondria-like organelles
(Fig. 5B, right panel) at PP1 and PP2. By contrast, few autophago-
somes were found at PP7 in uterine myocytes (data not shown).
Enhanced LC3 cytoplasm punctate staining patterns in the
postpartum myometrium of mice and humans
As the features of autophagy in tissues have been demonstrated
by LC3 immunohistochemistry with speciﬁc punctate patternsepresentative TUNEL assay of the uterine myocytes at (b) postpartum day 1 (PP1), (c)
se uterine endometrium was used as a positive control. Hematoxylin and eosin stain of
. The lower panel shows the magniﬁed images of the areas indicated by the box in the
he right side panel, representative Western blotting of activated caspase-3 (17/19 kDa
ours with 50 mM cisplatin (HeLa þ Cis) were used as a positive control and cells without
cells treated with 50 mM cisplatin for 24 hours (þCis) and cells without cisplatin (None).
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chemistry of the uterine myometrium on different gestation days
and in the postpartum period in mice and humans. The anti-LC3
antibody that recognizes both LC3-I and LC3-II produced inten-
sive positive cytoplasm staining with punctate localization pattern
(PP1, arrow) in mice (Fig. 6), suggestive of the occurrence of
autophagy. By contrast, faint and diffuse staining of LC3 was noted
in the myometrium at nonpregnancy (P0) and P14 in mice. In
human samples, diffuse, faint LC3 staining was noted during late-
term pregnancy (Case 1), whereas increased LC3 immunoactivity
with intensive cytoplasm staining with a punctate pattern (Case 2,
Case 3, arrows in inserts) was found, similar to PP1 mice myocytes,
in the myometrium of case tissues obtained from the two post-
partum uteri.
In conclusion, in this study we demonstrated that myometrial
hyperplasia occurs mainly in the early gestation period, whereas
cellular hypertrophy with increased cellular organelle production
occurs in a later stage of pregnancy. In the postpartum stage,Fig. 5. Autophagy developed in the uterine myocytes at postpartum. (A) Representative Wes
days. P0 indicates nonpregnancy; P2, P7, P14 and P21 indicate Day 1, Day 7, Day 14 and Da
respectively. Note that the level of LC3-II, a cleaved and active form of LC3, increases abrup
postpartum PP1, PP2 uterine myocytes by electron microscopy. The right side panel shows
mitochondria-like structures inside the autophagosomes.myometrial autophagy developed, but no obvious apoptosis of
myocytes was involved in the observed uterine involution.
Discussion
In this study, we demonstrated that uterine myometrial hyper-
plasia occurs in early pregnancy (within the ﬁrst 7 days in mice),
whereas hypertrophy, via an increase of myometrial cell mass but
without an increase of myometrial cell number, occurs later and is
mainly responsible for the uterine myocytes change during preg-
nancy. In the postpartum period, uterine involution arises as a
result of autophagy but without obvious apoptosis of the myo-
metrial cells. Although the roles of autophagy in the cell size
reduction of the size of smooth muscle cells has been suggested
previously, this study, to the best of our knowledge, is the ﬁrst to
report a simultaneously analysis using biochemical, histochemical,
and morphological methods to examine the autophagy in post-
partum uterine involution.tern blotting of LC3 of the uterine myometrium on different gestational and postpartum
y 21 of gestation, respectively; PP1 and PP7 indicate postpartum at Day 1 and Day 7,
tly on PP1. (B) Representative pictures of multiple cytoplasmic autophagic vacuoles in
the magniﬁed image of the area indicated by the box in the left side panel. Note the
Fig. 6. Enhanced cytoplasm staining of LC3 and punctate pattern in the postpartum myometrium of mice and humans. Representative immunohistochemical stain of LC3 of mice in
the uterine myometrium at day 0 (P0, nonpregnancy), Day 14 of gestation (P14), postpartum Day 1 (PP1); human uterine myometrium (Case 1, normal term, tissue obtained during
C/S; Case 2, Case 3, tissues obtained from postpartum hysterectomy). Note the faint, diffuse LC3 staining in P0, P14, and Case 1, whereas there is strong intensive LC3 staining in PP1,
Case 2, and Case 3. Note the cytoplasm punctate localization (arrows) staining pattern in PP1, Case 2, Case 3, indicative of increased autophagy activity in the uterine myometrium at
postpartum. The insets in PP1, Case 2, and Case 3 show the magniﬁed images of the area indicated by the red box.
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at term [1,2]. Generally, the multiparous woman typically has a
uterus that measures an average of 1.2 cm greater in all directions
sonographically and undergoes a 10e30-g weight increase
compared to the nulligravida [2,22]. Therefore, it is reasonable that
newuterinemyocytes develop (hyperplasia) during pregnancy, and
these new myoctes may not die or regress completely in the
postpartum period.
The proliferation of uterine smooth muscle cells in early gesta-
tion has been mentioned previously [23]. As shown in our results,
uterine hyperplasia occurredmainly in early pregnancy with a peak
Ki-67 staining at P2 (Fig. 3B) but little myocyte apoptosis activity
was detected postpartum (Fig. 4). We further directly characterized
the pattern and extent of smooth muscle cell proliferation in the
myometrium during pregnancy. Whereas the mechanisms under-
lying the proliferative phase of myometrial growth remain to be
determined, steroid hormones and the growth factor phosphoino-
sitide-3-kinase (PI3K)/mammalian target of rapamycin signaling
pathway may mediate this response [24,25].Over the course of pregnancy, the uterine smooth muscle layer
or myometrium is remodeled, and both cell hypertrophy and hy-
perplasia are evident [1]. This weight increase is accounted for
mainly by hypertrophy rather than by hyperplasia of the smooth
muscle cells, resulting in limited new myocytes [1,23]. Our results
further demonstrate that the hypertrophy is caused by intracellular
organelle expression increases during the pregnancy course. This
was indicated by increased expression of various organelle proteins
(actin, prohibin, calnexin, golgin-97). Both organelles and their
products mediatemyometrium hypertrophy during pregnancy. The
underlying mechanisms mediating the hypertrophic growth of
myometrial cells are most likely stimulated primarily by the me-
chanical forces of the expanding products of conception in the later
course of pregnancy [1].
Although themechanisms of postpartum uterus involution have
been studied previously [4e7], the causes responsible for the
reduction of uterine size are still not fully understood. The
apoptotic cell death of myocytes in postpartum uterine involution
has been suggested by Takamoto et al [4] and Shkurupiy et al [5].
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partum in ovine uterine myometrium using an in situ DNA end-
labeling method. Our data also indicate that no obvious apoptosis
occurred in postpartummice uterinemyometrium as monitored by
in situ TUNEL assays and caspase-3 activation assays. This failure to
observe postpartum myocyte apoptosis may indicate the relevant
changes are too faint to detect.
Normal cell and tissue growth, as well as development, requires
a well-controlled balance between protein synthesis and organelle
biogenesis versus protein degradation and organelle turnover. One
of the major pathways for degradation of cellular constituents is
autophagy. These degradative pathways are particularly important
during development, under certain environmental stress, and
during normal physiological condition [26e28]. Using electron
microscopy, Henell et al [7] suggested that that autophagy was a
likely mechanism in uterine involution. Our study clearly demon-
strates that autophagy but not apoptosis plays a signiﬁcant role in
postpartum involution. Following parturition, the mouse uterus
regains its nonpregnant weight within little more than 1 week. As
shown in Fig. 1, the most dramatic change in mouse uterine size
occurs on PP1. We accordingly observed that LC3-II, a marker of
autophagosome [20,21], presents a dramatic increase on PP1, more
so than at any other time point. After separation of the placenta,
strong uterine contraction occurs, which compresses the uterine
spiral, radial, and arcuate arteries and reduces myometrial blood
ﬂow, thus inducing starvation conditions for uterine myocytes.
Autophagy is then activated to deal with the nutrition deprivation.
Myocytes may undergo progressive atrophy and approach a stable
status without activating an apoptotic cascade. For determining
myometrium autophagy activity in pregnancy, in this study, we
used Western blotting, electron microscopy, and immunohisto-
chemistry. For many years, electron microscopy has been the “gold
standard” method for the study of autophagy. Apparently, only a
few cells can be observed by this method. For Western blotting
method, living cells are required. Neither method is suitable for
formalin-ﬁxed parafﬁn-embedded tissues, which are the most
available form in preserved tissue samples. More recently, immu-
nohistochemistry was introduced into autophagy research, making
the phenomenon accessible by light microscopy [16,29e31].
Martinet et al [29] suggest that immunohistochemical analysis is
possible for LC3, but only where the protein was overexpressed, for
example in GFP-LC3 transgenic animals. Using an LC3 antibody,
Sivridis et al [30,31] performed a standard immunohistochemistry
study by light microscopy in various cancer tissues. The reliability
of the results was conﬁrmed by electron microscopy, breast cancer
cell xenografts, and colon cancer cell spheroids experiments. The
researchers found there are three basic patterns of LC3 reactivity
that could be conveniently detected by light microscopydthe
diffuse cytoplasmic, the cytoplasmic/perinuclear, and the so-called
“stone-like” structures that were exclusively observed in malignant
epithelial tissues. Holt et al [16] developed an immunohistochem-
istry (IHC) method to detect LC3 in human tumor xenografts tissue
by testing different antigen retrieval agents, protein blocking
buffers, and detection methods. They demonstrated the diffuse
pattern of LC3-I, and the localized, distinct punctate pattern of LC3-
II. In our study, we used an LC3 antibody (LC3; 1:1000, Medical and
Biological Laboratories, Co., Ltd., Nagoya, Japan) that recognized
both LC3-I and LC3-II [10]. This allowed for the identiﬁcation of the
increased autophagy-speciﬁc autophagosome membraneebound
LC3-II via Western blotting (Fig. 5A), which was subsequently
conﬁrmed by electron microscopy of the autophagosome (Fig. 5B).
This antibody, which is suggested to be reliable in IHC suggested by
the manufacturer, was also used in our immunohistochemical
study. Following Holt et al's [16] IHC protocol, our immunohisto-
chemical study in uterine myometrium found a punctate pattern ofLC3 (Fig. 6, PP1, Case 2, Case 3) at postpartum with an enhanced
cytoplasmic staining compared to before delivery (Case 1), sug-
gesting increased autophagy activity in postpartum uterine small
muscle cells. The abrupt increase in autophagy activity in the
myometrium, resulting inmyocytes atrophy at PP1, may account for
the dramatic decrease in uterine size during uterine involution as
shown in Fig. 1A.
In conclusion, in this study we demonstrate that autophagy
occurs abruptly in postpartum uterine involution without an
obvious increase of myocyte apoptosis. Given the myocyte prolif-
eration in the early stage of pregnancy, the uterine size or weight
will not regress to the prepregnancy value. Therefore, the uterine
sizes of multiparous woman are usually larger than in nulligravidas.
This result ﬁts our clinical observations. The results of this study
provide implications for our understanding of the myometrial
functional adaptations during pregnancy, and the physiological role
of autophagy during uterine remodeling events occurring in the
postpartum period.
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